Navigation Links
Bioactive Peptide synthesis from Primm Biotech, Inc.

ProductsBioactive Peptide synthesis from Primm Biotech, Inc.
Company Primm Biotech, Inc.
Item Bioactive Peptide synthesis
Price 
Description Custom design

The Bioactive peptides are molecules of peptidic nature or origin which display a biological behaviour or activity which can be developed at the industrial level for pharmaceutical, diagnostic, chemical and agro-food applications. In this way it is possible to obtain modified peptides with superior properties for therapeutic applications. Primm offers a design strategy for developing your Bioactive peptides.

Info Primm Biotech, Inc.Primm Biotech, Inc.
Box 425695 Kendall Square
Cambridge, MA 02142

Call Primm Biotech, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-526-1665
Customer Service: 800-893-4388
Fax Number: 617-325-2703
Web Site: http://www.primmbiotech.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
2. Peptide Design and Custom Synthesis from Global Peptide Services, LLC.
3. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
4. Human and Mouse RAR Neutralizing Peptide from ABR-Affinity BioReagents
5. Epitope Peptide Microarray - Comprehensive Service from LC Sciences
6. Custom Peptide Microarray - Comprehensive Service from LC Sciences
7. Peptide Synthesis from Sigma-Genosys
8. Rat rab 3D Neutralizing Peptide from ABR-Affinity BioReagents
9. Rat SAP97 Neutralizing Peptide from ABR-Affinity BioReagents
10. Rat SCAMP 5 Neutralizing Peptide from ABR-Affinity BioReagents
11. Ph.D. Peptide Display Cloning System from New England Biolabs
...
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
Mouse monoclonal antibody raised against a partial recombinant SCARB2. NCBI Entrez Gene ID = SCARB2...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Biology Products:
(Date:3/13/2017)... HAMBURG, Germany , March 13, 2017 Future of ... ... DERMALOGs Face Matching enables to match ... characteristics forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for ...
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/1/2017)...  Aware, Inc. (NASDAQ: AWRE), a leading supplier of ... Moberg has resigned, effective March 3, 2017, as ... and Treasurer of Aware citing a desire to retire.  ... of the Board of Directors of Aware. ... and co-President, General Counsel has been named Chief Executive ...
Breaking Biology News(10 mins):
(Date:3/30/2017)... 2017  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... agreements with Nippon Shinyaku, Co., Ltd. for Defitelio ® ... daunorubicin liposome injection), or CPX-351, in Japan ... agreements, Nippon Shinyaku will receive exclusive rights to develop ... in return for an upfront payment to ...
(Date:3/29/2017)... 29, 2017 Patients are the most compelling ... Behring awards Local Empowerment for Advocacy Development (LEAD) grants ... These groups tackle complex legislative and public policy issues ... and in statehouses across the U.S. ... awarded to New England Hemophilia Association (NEHA), Neuropathy Action ...
(Date:3/29/2017)... WuXi Biologics, a leading open-access R&D ... and a WuXi AppTec Affiliate, today announced that ... Excellence Award from IMAPAC, a leading consulting firm. ... recognize outstanding leaders and trend-setters of today, and ... biomanufacturing experts in the industry, along with the ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
Breaking Biology Technology: